Biosimilars Guidances
Updated: 4/28/2015
Updated: 4/28/2015
Scientific Considerations in Demonstrating Biosimilarity to a Reference Product; Guidance for Industry (PDF - 169KB)
Posted: 4/28/2015
Posted: 4/28/2015
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment